Shinobi Therapeutics

Developer of immune-evasive iPSC-derived cell treatments for various diseases

placeSan Francisco, California, United States calendar_todayFounded 2023 language shinobitx.com

Social engagement

Social engagement: 5.2K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Eight Roads Ventures, F-Prime Capital, EQT.

Investor typeCountShare
Venture capital660%
Private equity220%
Other / undisclosed220%

Recent activity

18 Feb 2026
Partnership
AMED
9 Feb 2026
Partnership
Kaliforni
10 Nov 2025
Leadership hire
Independent Director and Board Chair
Coming soon